CHME
China Medicine Corporation
OTC Markets OTCPKUSDEQUITY
DELAYED
Last price
0.02
▼ 0.03 (61.75%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
—
Prev close
0.05
Day high
0.04
Day low
0.04
Volume
131.50K
Market cap
—
P/E (TTM)
—
52W range
0.00 – 0.06
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
-49.51%
-48.1%
1M
+2.50%
-1.2%
3M
+2.50%
-0.6%
6M
-41.43%
-52.5%
YTD
-48.75%
-61.0%
1Y
+3,316.67%
+3,296.7%
3Y
+3,316.67%
+3,242.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.03
-41.13% from price
SMA 20
0.03
-25.21% from price
SMA 50
0.03
-23.32% from price
SMA 100
0.02
-13.53% from price
SMA 200
0.03
-25.14% from price
EMA 12
0.03
-35.77% from price
EMA 26
0.03
-28.36% from price
EMA 50
0.03
-22.75% from price
RSI (14)
42.2
Neutral
MACD (12,26,9)
0.00
Hist 0.00
ATR (14)
0.01
27.00% of price
Realised vol 30D
351.6%
Annualised
Bollinger upper
0.05
20, 2σ
Bollinger lower
0.00
20, 2σ
50 / 200 cross
Death
0.03 vs 0.03
Trend bias
Below 200
-25.14%
Risk profile
Beta vs SPY
-7.07
Less volatile than market
Correlation to SPY
-0.04
Largely independent
Realised vol 30D
351.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-74.8%
Peak to trough
Max drawdown 5Y
-99.6%
Peak to trough
ATR 14
0.01
27.00% of price
Beta (reported)
—
5Y monthly, from filing
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.